about
Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with PsoriasisEtanercept in psoriasis: the evidence of its therapeutic impact.Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins.Overview of psoriasis.Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severityInterleukin 6 and 8 levels in plasma and fibroblast cultures in psoriasis.The role of T cells in psoriasis.Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasis.Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis.Psoriasis: immunopathogenesis and evolving immunomodulators and systemic therapies; U.S. experiences.Etanercept in psoriasis.Acquired latent tuberculosis infection in psoriasis patients treated with etanercept in the People's Republic of China.Biologic agents in psoriasis.Etanercept: long-term clinical experience in rheumatoid arthritis and other arthritis.Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasisManagement and costs of severe psoriasis: the role of new biologics.Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder.Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.Nuclear envelope localization of Ran-binding protein 2 and Ran-GTPase-activating protein 1 in psoriatic epidermal keratinocytes.Expression of Toll-like Receptor 2 in Cultured Human Keratinocytes: The Effect of Bacterial Antigens, Cytokines and Calcium Concentration.Immortalized N/TERT keratinocytes as an alternative cell source in 3D human epidermal models.Current concepts in the pathogenesis of psoriasis.Development and validation of human psoriatic skin equivalents.Role of NF-κB in the pathogenesis of psoriasis elucidated by its staining in skin biopsy specimens.Expression of NF-kappaB in epidermis and the relationship between NF-kappaB activation and inhibition of keratinocyte growth.A Comprehensive Study of Tumor Necrosis Factor-Alpha Genetic Polymorphisms, its Expression in Skin and Relation to Histopathological Features in Psoriasis.Treatment of psoriasis by using Hijamah: A case report.Topical isoflavonoids reduce experimental cutaneous inflammation in mice.Lack of racial differences in the pharmacokinetics of subcutaneous golimumab in healthy Japanese and Caucasian male subjects.Sarcoidosis associated with psoriasis vulgaris.TNFα- and IL-17A-mediated S100A8 expression is regulated by p38 MAPK.Psoriasis treatment patterns with etanercept and adalimumab in a United States health plan population.IgG class antibodies from psoriasis patients recognize the 60-KDa heat-shock protein of Streptococcus pyogenes.CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.Immunophenotyping of T cells in the peripheral circulation in psoriasis.Treatment of severe recalcitrant plaque psoriasis with single-dose intravenous tumour necrosis factor-alpha antibody (infliximab).Genetic effects of single nucleotide polymorphisms in JAK2 and STAT5A genes on susceptibility of Chinese Holsteins to mastitis.Differential expression of toll-like receptor mRNAs in recurrent aphthous ulceration.The evaluation of the clinical effect of topical St Johns wort (Hypericum perforatum L.) in plaque type psoriasis vulgaris: a pilot study.Vascular endothelial growth factor gene polymorphisms increase the risk to develop psoriasis
P2860
Q28554923-FAFD3B65-3F2F-487D-8F7C-45773F631A2DQ34450544-8E102B5A-12E9-4708-93A5-C93BDBE5C491Q34451039-924FC518-420A-46B5-864E-21B488EB6354Q34551058-108F2880-82CC-4832-B4B3-0357C07B511FQ34945351-B07E4225-6286-4CC2-87AC-30ACDA9CAA61Q35039946-FCBA04E2-29AD-48D8-8719-681F36AE57DFQ35110104-88372BF4-0575-4EFA-A5B9-2D6275BB9730Q35131199-D0A3E4A0-E0B8-42B4-8224-25B50F451BE3Q35203839-23093858-EC99-41BA-9BF5-BE97CCDBBB1AQ35843827-5FA00CB7-486E-4A44-A0A2-8AAEDE534C96Q35906931-767EA684-405C-422C-B74C-237E1C7C60C5Q36176854-9DE8B994-17BE-4348-94B0-7C00F54C8C24Q36620700-CE947CD8-882C-41D1-A09B-808413222A71Q36847326-C19222D5-FBC7-4FE9-B4EF-890815754B0FQ36855744-2C1D4E68-34A5-43F8-B4C5-86113D1C2A5AQ37609371-B6257E75-FBC9-4E5B-BC0F-3A18CC238178Q37617085-316CE634-90CE-470A-90D6-BF21BC496FE3Q38582187-9D1CF2F4-BE45-4876-ABC3-FC2F4FA8D5D9Q39033448-CF6F0BF9-9047-4C5E-AE31-96822618BEBFQ40250189-2A92447A-F340-4148-B23A-5FFC0AFA610BQ41717499-41F1AC24-A03C-491A-AA39-4DB080C461A4Q42283126-73446B4D-4F0D-496E-A5CA-0AAAC5E06890Q42423385-A7EC600A-225C-4A61-9773-B8DDF1965192Q42437751-91674943-094A-43CA-B030-5124AAF6087FQ42441349-3ECCA963-36D6-42CF-A952-5E5020967977Q42447920-78FE66C8-1747-4036-BE0D-64FCF63833A5Q43087721-88775965-BB54-4A63-B27D-D3CE010120EBQ43138001-DA454953-3FF7-4B7C-9929-9A68409A6A8BQ43172644-56E6C54F-F186-418C-9FB8-8A2DB0ACCDEAQ43587348-DE8413C1-E61E-482A-B9F3-DF5B5C1B2DDDQ44044237-30C44C15-C701-430B-8C06-7C1565FCD2A6Q45805086-F8962450-E6F8-47DF-9540-135CB9005FBEQ47675133-3AE0A831-EC84-47E3-ACAC-4A3991828662Q48302992-4CFCF1E5-4893-486E-B247-DB085E72F2C3Q51603409-D2DB21DA-3102-411C-9C37-47388D197A9FQ53387654-58FEA58C-E8A2-4A55-8D09-7AB63BF21516Q54323666-BCD81947-4A0E-472E-A28A-11B3DA44F6E6Q54374072-AB665443-B6B3-428B-B00E-9C9A7D1B740BQ55056080-F26855DE-88CD-4901-85F8-D70ECDEAD0A6Q57613985-67FF24FD-616F-452D-9B20-C185E1560EC5
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cytokines in psoriasis.
@ast
Cytokines in psoriasis.
@en
type
label
Cytokines in psoriasis.
@ast
Cytokines in psoriasis.
@en
prefLabel
Cytokines in psoriasis.
@ast
Cytokines in psoriasis.
@en
P2860
P1476
Cytokines in psoriasis.
@en
P2093
P2860
P304
P356
10.1046/J.1365-4362.1999.00622.X
P577
1999-04-01T00:00:00Z